Blackwood C, Cadet J
Curr Res Neurobiol. 2022; 2.
PMID: 35548327
PMC: 9090195.
DOI: 10.1016/j.crneur.2021.100023.
Honkaniemi J, Rummukainen J, Vaananen P, Vuorialho M
Case Rep Neurol. 2022; 14(1):31-37.
PMID: 35350289
PMC: 8921954.
DOI: 10.1159/000521865.
Martignetti L, Sun W
Cureus. 2022; 14(1):e21461.
PMID: 35223245
PMC: 8858082.
DOI: 10.7759/cureus.21461.
Melikishvili A, Patel B, Hasbani D, Carvalho K
Child Neurol Open. 2021; 8:2329048X211030757.
PMID: 34377736
PMC: 8327008.
DOI: 10.1177/2329048X211030757.
Sidhu M, Mekala A, Ronen J, Hamdan A, Mungara S
Cureus. 2021; 13(6):e15865.
PMID: 34327090
PMC: 8301723.
DOI: 10.7759/cureus.15865.
Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: A systematic review.
Winstanley E, Mahoney 3rd J, Castillo F, Comer S
Drug Alcohol Depend. 2021; 226:108838.
PMID: 34271512
PMC: 8889511.
DOI: 10.1016/j.drugalcdep.2021.108838.
Machine learning: assessing neurovascular signals in the prefrontal cortex with non-invasive bimodal electro-optical neuroimaging in opiate addiction.
Ieong H, Gao F, Yuan Z
Sci Rep. 2019; 9(1):18262.
PMID: 31797878
PMC: 6892956.
DOI: 10.1038/s41598-019-54316-6.
"CHOICES": An acronym to aid in delineating potential causes of non-metabolic, non-infectious acute toxic leukoencephalopathy.
Koksel Y, Ozutemiz C, Rykken J, Ott F, Cayci Z, Oswood M
Eur J Radiol Open. 2019; 6:243-257.
PMID: 31309133
PMC: 6607360.
DOI: 10.1016/j.ejro.2019.06.005.
Neuropathology of substance use disorders.
Cadet J, Bisagno V, Milroy C
Acta Neuropathol. 2013; 127(1):91-107.
PMID: 24292887
PMC: 7453825.
DOI: 10.1007/s00401-013-1221-7.
Association of frontal gray matter volume and cerebral perfusion in heroin addiction: a multimodal neuroimaging study.
Denier N, Schmidt A, Gerber H, Schmid O, Riecher-Rossler A, Wiesbeck G
Front Psychiatry. 2013; 4:135.
PMID: 24151470
PMC: 3801154.
DOI: 10.3389/fpsyt.2013.00135.
Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study.
Byrd D, Robinson-Papp J, Rivera Mindt M, Mintz L, Elliott K, Lighty Q
J Int Neuropsychol Soc. 2013; 19(4):463-73.
PMID: 23446056
PMC: 3815532.
DOI: 10.1017/S1355617712001634.
Beta-amyloid protein-containing inclusions in skeletal muscle of apolipoprotein-E-deficient mice.
Robertson T, Dutton N, Martins R, Roses A, Kakulas B, Papadimitriou J
Am J Pathol. 1997; 150(2):417-27.
PMID: 9033257
PMC: 1858271.
Tubular aggregates and partial cytochrome c oxidase deficiency in skeletal muscle of patients with AIDS treated with zidovudine.
Chariot P, Benbrik E, Schaeffer A, Gherardi R
Acta Neuropathol. 1993; 85(4):431-6.
PMID: 8386898
DOI: 10.1007/BF00334455.
HIV-specific changes in the motor performance of HIV-positive intravenous drug abusers.
von Giesen H, Hefter H, ROICK H, Mauss S, Arendt G
J Neurol. 1994; 242(1):20-5.
PMID: 7897448
DOI: 10.1007/BF00920570.
Painful sciatic neuropathy after heroin overdose.
Gille M, Delbecq J, Depre A, Van den Bergh P
J Neurol. 1995; 242(7):478-80.
PMID: 7595681
DOI: 10.1007/BF00873553.
Acute myelopathy in association with heroin addiction.
Ell J, Uttley D, Silver J
J Neurol Neurosurg Psychiatry. 1981; 44(5):448-50.
PMID: 7264695
PMC: 490993.
DOI: 10.1136/jnnp.44.5.448.
Narcotic abuse: neurological complications in pediatric and adolescent patients.
FRENCH J, Kaufman D
J Natl Med Assoc. 1974; 66(5):426-31, 425.
PMID: 4414776
PMC: 2609254.
Development of tolerance to street heroin in addicted and nonaddicted primates.
Reichman L, Shim C, Baden M, Richter R
Am J Public Health. 1973; 63(9):801-3.
PMID: 4198838
PMC: 1775245.
DOI: 10.2105/ajph.63.9.801.
Heroin myelopathy: a case report.
Guidotti M, PASSERINI D, Brambilla M, Landi G
Ital J Neurol Sci. 1985; 6(1):99-100.
PMID: 3997468
DOI: 10.1007/BF02229226.
A case of "myopathy with tubular aggregates" with increased muscle fibre sensitivity to caffeine.
Orimo S, Araki M, Ishii H, Ikeda M, Kurosawa T, Arai M
J Neurol. 1987; 234(6):424-6.
PMID: 3655846
DOI: 10.1007/BF00314090.